Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC16007 structure
    GC16007Methylthiouracil
    CAS: 56-04-2
    纯度: >98.00%

    甲基硫氧嘧啶是一种抗甲状腺药物。

  • GC16023 structure
    GC16023Bax inhibitor peptide P5
    CAS: 579492-83-4

    Bax inhibitor

  • GC16037 structure
    GC160377BIO
    CAS: 916440-85-2

    A caspase-independent (nonapoptotic) cell death inducer

  • GC16039 structure
    GC16039LJH685
    CAS: 1627710-50-2
    纯度: >98.00%

    An inhibitor of RSKs

  • GC16055 structure
    GC16055SMIP004
    CAS: 143360-00-3
    纯度: >98.50%

    SMIP004 是一种 SKP2 E3 连接酶抑制剂,可下调 SKP2 并稳定 p27。 SMIP004 是人前列腺癌细胞的癌细胞选择性凋亡诱导剂。

  • GC16077 structure
    GC16077Deracoxib
    CAS: 169590-41-4
    纯度: >99.50%

    An NSAID and selective COX-2 inhibitor

  • GC16145 structure
    GC16145NVP-BGT226
    CAS: 1245537-68-1
    纯度: >99.50%

    A dual PI3K and mTOR inhibitor

  • GC16151 structure
    GC16151NSC348884
    CAS: 81624-55-7
    纯度: >98.00%

    A nucleophosmin inhibitor

  • GC16167 structure
    GC16167K 858
    CAS: 72926-24-0
    纯度: >99.50%

    An inhibitor of Eg5

  • GC16179 structure
    GC16179NSC59984
    CAS: 803647-40-7
    纯度: >99.50%

    A p53 reactivator

  • GC16208 structure
    GC16208HO-3867
    CAS: 1172133-28-6
    纯度: >98.00%

    A selective STAT3 inhibitor

  • GC16214 structure
    GC16214DEL-22379
    CAS: 181223-80-3
    纯度: >98.00%

    An inhibitor of ERK dimerization

  • GC16233 structure
    GC16233Tacrolimus (FK506)
    CAS: 104987-11-3
    纯度: >99.90% / >98.00%

    他克莫司 (FK506) 是一种具有强效免疫抑制作用的大环内酯类抗生素,从筑波链霉菌中分离出来,以前曾用于预防人类同种异体移植和治疗自身免疫性疾病。

  • GC16237 structure
    GC16237Apocynin
    CAS: 498-02-2
    纯度: >99.50%

    Apocynin是一种天然存在的苯乙酮类化合物,可作为NADPH氧化酶复合物的强效抑制剂,IC 50 值为10μM。

  • GC16258 structure
    GC16258PD-1/PD-L1 Inhibitor 3
    CAS: 1629654-95-0

    A PD-1/PD-L1 interaction inhibitor

  • GC16278 structure
    GC16278A-1210477
    CAS: 1668553-26-1
    纯度: >98.50%

    A selective Mcl-1 inhibitor

  • GC16296 structure
    GC16296MI-773
    CAS: 1303607-07-9
    纯度: >98.00%

    MI-773 是一种有效的 MDM2-p53 蛋白-蛋白相互作用 (PPI) 抑制剂,对 MDM2 具有高结合亲和力 (Kd=8.2 nM)。 MI-773 具有抗肿瘤活性。

  • GC16310 structure
    GC16310FTI 277 HCl
    CAS: 180977-34-8
    纯度: >99.00%

    FTI 277 HCl是一种强效且具有选择性的法尼基转移酶(FTase)抑制剂,IC 50 值为0.5nM,较香叶酰基香叶转移酶I(GGTase I)选择性高出约100倍。

  • GC16316 structure
    GC16316Q-VD-OPh hydrate
    CAS: 1135695-98-5
    纯度: >99.50% / >97.00%

    Q-VD-OPh hydrate是一种广谱、可渗透细胞、高效且无毒的caspase抑制剂,对重组caspase1,3,8和9的IC 50 值在25-400nM范围内。

  • GC16350 structure
    GC16350Actinonin
    CAS: 13434-13-4
    纯度: >99.00%

    Actinonin是一种肽模拟抗生素,能够抑制enkephalin-aminopeptidase、enkephalinase A和 dipeptidylaminopeptidase,IC 50 值分别为0.39μM、5.6μM和1.1μM。

  • GC16362 structure
    GC16362AD57 (hydrochloride)
    CAS: 2320261-72-9

    A polypharmacological cancer therapeutic

  • GC16371 structure
    GC16371Solasodine
    CAS: 126-17-0
    纯度: >98.00%

    An alkaloid with diverse biological activities

  • GC16375 structure
    GC16375(±)-Jasmonic Acid methyl ester
    CAS: 39924-52-2
    纯度: >98.00%

    (±)-Jasmonic Acid methyl ester是一种重要的天然植物信号分子和植物激素,具备多种生物学活性。

  • GC16380 structure
    GC16380AZD8055
    CAS: 1009298-09-2
    纯度: >99.50%

    AZD8055是一种新型的ATP竞争性mTOR抑制剂,IC50 为0.8 nmol/L,Ki为1.3 nmol/L。